CHEO Research Institute Logo
Decrease Text SizeIncrease Text SizeFacebookTwitterYoutube

photo of researcher holding a beaker

Hugh McMillan, MD, MSc, FRCPC, FAAN photo of Dr. Hugh McMillan
Clinical Investigator, CHEO Research Institute
Physician, Division of Neurology, CHEO
Associate Professor, Department of Pediatrics,
Faculty of Medicine, University of Ottawa
Member, Muscular Dystrophy of Canada Scientific Advisory Committee

hmcmillan@cheo.on.ca
613-737-7600 Ext. 1605
Research Practice Areas:
Current Research:
Dr. McMillan current research interests include clinical research, clinical trials (investigator-initiated and sponsor-initiated studies) as well as translational research in cooperation with basic scientists.
Biography:
Dr. McMillan is an Associate Professor of Pediatrics at the University of Ottawa, a Pediatric Neurologist and Neuromuscular specialist at the Children's Hospital of Eastern Ontario (CHEO) and a Clinical Investigator at the CHEO Research Institute. He is the Program Director of the Pediatric Neurology Residency Training Program. His area of Clinical expertise is caring for children and youth with inherited and acquired disorders of peripheral nerve, muscle and neuromuscular junction. He follows children in the Neuro-Oncology clinic as well as a General Child Neurology clinic. His research interests include clinical research, clinical trials (investigators-initiated and sponsor-initiated studies) as well as translational research in cooperation with basic scientists. He has been an author or co-author of more than 55 publications in peer-reviewed journals. He recently co-edited a textbook, "Pediatric Electromyography: Concepts and Clinical Applications". He is active in the community as a Member of the Muscular Dystrophy of Canada, Scientific Advisory Board and is the Chairperson for the Canadian Pediatric Neuromuscular Group.
Sample Publications:
Ward L, Kinnett K, Bonewall L & Adachi JD, Bachrach L, Bellido T, Brotto M, Donovan J, Hoffman E, Leonard MB, McMillan H, Novotny S, Rafael-Fortney JA, Rauch F, Warden S. Morbidity due to Osteoporosis in DMD: The Path Forward Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop May 12-13, 2016, Bethesda, Maryland, USA. Neuromuscular Disorders 2017

McMillan HJ
, Jansen GH, Koujok K, Milman N, Duffy C, Watanabe Duffy K. Mononeuritis multiplex associated with minocycline use in an adolescent. Muscle Nerve. 2017 May 31 [epub ahead of print]

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald CM, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemp Clin Trials. 2017

Ma J, McMillan HJ, Karaguzel G, Goodin C, Wasson J, Matzinger MA, DesClouds P, Cram D, Page M, Konji VN, Lentle B, Ward LM. The time and determinants of first fracture in boys with Duchenne muscular dystrophy. Osteoporos Int 2017: 28(2): 597-608.

Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson D, Sherman ML, Escolar D, Attie KM. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial. Muscle Nerve. Muscle Nerve 2016.

Wagner JD, Huang L, Tetreault M, Majewski J, Boycott KM, Bulman DE, Care4Rare Canada Consortium, Dyment DA, McMillan HJ, Autosomal recessive axonal polyneuropathy in a sibling pair due to a novel homozygous mutation in IGHMBP2. Neuromuscul Disord 2015;25(10):794-9
Take Action
Quick Links

Our Researchmagnifying glass

abcefg hijklmnopqrst uvwxyz